Research & Innovation
Published on
August 2, 2023

The Role of Mitochondria in Mood Disorders

mitochondria and mood disorders

Share this article:

In short: Mitochondria are responsible for ATP production and play a role in the metabolism of reactive oxygen species, calcium homeostasis, and synaptic plasticity. In the brain—which is highly energy-demanding—mitochondrial dysfunction is associated with mood disorders. Altered energy metabolism and increased oxidative stress may thus play a key role in the development of certain psychiatric disorders.

The crucial role of mitochondria in mood disorders

According to a recent study published in *Frontiers in Psychiatry*, mitochondria are cellular organelles known to be involved in various biological processes, such as the production of adenosine triphosphate (ATP), the metabolism of reactive oxygen species (ROS), calcium (Ca2+) homeostasis, cell death and survival, as well as synaptic plasticity (Scaini et al., 2021). In the brain, which consumes large amounts of ATP and lacks the ability to store it, mitochondrial activity is crucial for modulating neuronal activity, short- and long-term neuronal plasticity, cellular resilience, and behavioral adaptations, primarily through its effects on long-term potentiation.

Mitochondrial dysfunction and mood disorders

Mitochondrial dysfunction is considered a multifactorial phenomenon because it can have multiple causes and affects numerous neurobiological processes, impairing synaptic function and promoting apoptosis, which may play a role in the potentially progressive long-term course of certain psychiatric disorders (Scaini et al., 2021). Several studies have focused on the presence of impaired energy metabolism in patients with mood disorders, suggesting that mitochondrial dysfunction may play an important role in various aspects of these conditions.

The various effects of photobiomodulation (PBM) on the brain

The Role of Mitochondria in Energy Production and Oxidative Stress

Every cell depends on energy production by mitochondria, with a much higher demand in neurons, particularly in gray matter, which contains a large number of synapses and mitochondria (Scaini et al., 2021). In addition to energy production, mitochondria are sources of substrates for cell growth and play crucial roles in oxidative/nitrosative stress, cellular resilience, and cell death pathways.

Mitochondria and neurogenesis

Mitochondria also play a critical role in neurogenesis, the process by which neural stem cells proliferate and differentiate into new neurons (Scaini et al., 2021). Numerous studies have shown that the mitochondrial genome and mitochondrial proteins are necessary for neuronal differentiation.

Mitochondria are cellular organelles involved in a number of biological processes, playing a key role in maintaining neuronal homeostasis. They are involved in energy production, ROS metabolism, calcium homeostasis, apoptosis, synaptic plasticity, and neurogenesis, modulating neuronal activity and preventing neuronal damage (Scaini et al., 2021). In mood disorders, mitochondrial dysfunction leads to impaired cellular homeostasis, resulting in the dysregulation of these mechanisms.

In short, research on the role of mitochondria in mood disorders is a rapidly expanding field. Current evidence suggests that mitochondrial dysfunction may play a key role in the etiology of these disorders (Scaini et al., 2021).

However, further research is needed to better understand the specific mechanisms by which mitochondria contribute to these disorders and to develop therapeutic strategies that target mitochondria.

Reference: Scaini , G., Rezin, G. T., Carvalho, A. F., Streck, E. L., Berk, M., & Quevedo, J. (2021). Mitochondrial Dysfunction in Mood Disorders: From Pathophysiology to Treatment. Frontiers in Psychiatry, 12, 546801.

See also

Our News

Similar articles, tips, and discoveries

All the latest news
Research & Innovation
Photobiomodulation Research Update - June 2026
Our summary of the 58 publications on photobiomodulation that were published or indexed in June 2026. Topics include: oral mucositis confirmed by a multicenter randomized trial; PBM for pain associated with temporomandibular disorders; and more recent research in cognition, sleep, and presbyopia.
Read the article
Research & Innovation
Photobiomodulation and Chemotherapy: The Study That Restores Memory
A study by the Valenciennes Hospital (CHV) confirms that transcranial photobiomodulation (using the Vielight Duo 4 headset) restores memory after chemotherapy: 93.5% of patients showed improvement.
Read the article
Research & Innovation
Photobiomodulation Research Update - May 2026
Our May 2026 scientific review compiles 30 publications on photobiomodulation, including several meta-analyses and randomized trials. Overview by clinical field: pain, supportive oncology, neurology, oral health, sports medicine, wound healing, and ophthalmology.
Read the article
Research & Innovation
PBM Research Update: 17 new publications in one week
17 scientific publications on photobiomodulation in one week: oncology, pain management, dermatology, neurology, and cellular mechanisms.
Read the article
Research & Innovation
Photobiomodulation Research Update - April 2026
As of April 2026, 144 PubMed publications on photobiomodulation had been indexed. Our team selected 18 notable clinical studies in the fields of neurology, supportive oncology, ophthalmology, dentistry, sports medicine, and pain management.
Read the article